Major Growth Boosters:
Increase in R&D spending of pharmaceutical & biotechnology companies, growth in biologics sector, high prevalence of lifestyle disease, increasing in adoption of protein based drugs over non-protein based drugs and increase of protein stability and circulating half-life with the help of PEGylation are the major drivers of market. On the other hand drug failure and recalls is the major factor restraining the growth of this market.
Expected Revenue Growth:
The global PEGylated proteins market is expected to reach USD 1,137.8 Million by 2021 from USD 690.6 Million in 2016, at a CAGR of 10.5% between 2016 and 2021.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19242378
Research Methodologies Followed for This Study:
A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global PEGylated proteins market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.
Geographical Growth Scenario:
The geographic segments included in this report are North America, Europe, Asia, and Rest of the World (RoW). Geographic analysis reveals that North America accounted for the largest share of the global PEGylated proteins market in 2016. Growth in this market can be attributed to the increased adoption of biologics drugs such as monoclonal antibodies, erythropoietin and interferon for the treatment of chronic diseases, increasing government funding and grants for research activities.
Target audience for this report:
# Academic research institutes
# Pharmaceutical companies
# Biotechnology Companies
# PEGylation products manufacturing companies
# Contract research organizations (CROs)
# Market research & consulting firms
Major Leaders:
The major players in PEGylated proteins market include Merck Millipore (U.S.), Thermo Fisher Scientific, Inc. (U.S.), NOF Corporation (Japan), JenKem Technology USA, Inc. (U.S.), Creative PEGworks (U.S), Celares GmbH (Germany), Quanta BioDesign, Ltd. (U.S.), Biomatrik, Inc, (China), Iris Biotech GmbH (Germany) , Laysan Bio, Ltd. (U.S.).
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=19242378
